NEUTROPEG pegfilgrastim 6 mg/0.6 mL solution for injection pre-filled syringe

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

공공 평가 보고서 공공 평가 보고서 (PAR)
30-08-2019

유효 성분:

Pegfilgrastim, Quantity: 6 mg

제공처:

Accord Healthcare Pty Ltd

약제 형태:

Injection, solution

구성:

Excipient Ingredients: glacial acetic acid; polysorbate 20; sodium hydroxide; sorbitol; water for injections

관리 경로:

Subcutaneous

패키지 단위:

1 prefilled syringe

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

For the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

제품 요약:

Visual Identification: clear and colourless liquid; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

승인 상태:

Registered

승인 날짜:

2019-08-19